scispace - formally typeset
R

Robert S. Stern

Researcher at Boston University

Publications -  772
Citations -  69000

Robert S. Stern is an academic researcher from Boston University. The author has contributed to research in topics: Chronic traumatic encephalopathy & Psoriasis. The author has an hindex of 120, co-authored 761 publications receiving 62834 citations. Previous affiliations of Robert S. Stern include American Academy of Dermatology & Rhode Island Hospital.

Papers
More filters
Journal ArticleDOI

Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.

TL;DR: This work reviews 48 cases of neuropathologically verified CTE recorded in the literature and document the detailed findings of CTE in 3 professionalathletes, 1 football player and 2 boxers.
Journal ArticleDOI

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Adam C. Naj, +156 more
- 01 May 2011 - 
TL;DR: The Alzheimer Disease Genetics Consortium performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1), two replication stages (stages 2 and 3), and both joint analysis and meta-analysis approaches were used.
Journal ArticleDOI

The spectrum of disease in chronic traumatic encephalopathy

TL;DR: The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein.
Journal ArticleDOI

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

TL;DR: This study suggests that an illustrated atlas is a useful tool for standardizing the diagnosis of acute severe bullous disorders that are attributed to drugs or infectious agents.
Journal ArticleDOI

Severe Adverse Cutaneous Reactions to Drugs

TL;DR: Adverse cutaneous reactions to drugs are frequent, affecting 2 to 3 percent of hospitalized patients, and prompt withdrawal of the offending drug is often the most important action to minimize morbidity.